Silencers versus stabilizers in amyloid cardiomyopathy. Are we asking the wrong questions?
Saved in:
| Title: | Silencers versus stabilizers in amyloid cardiomyopathy. Are we asking the wrong questions? |
|---|---|
| Authors: | Falk RH; Brigham and Women's Hospital Amyloidosis Program and Section of Cardiology, Brigham and Women's Hospital, Boston, MA, USA., Cuddy SAM; Brigham and Women's Hospital Amyloidosis Program and Section of Cardiology, Brigham and Women's Hospital, Boston, MA, USA., Itzhaki Ben Zadok O; Brigham and Women's Hospital Amyloidosis Program and Section of Cardiology, Brigham and Women's Hospital, Boston, MA, USA.; School of Medicine, Tel Aviv University, Tel Aviv, Israel. |
| Source: | European journal of heart failure [Eur J Heart Fail] 2025 Apr; Vol. 27 (4), pp. 623-627. Date of Electronic Publication: 2025 Feb 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0844 (Electronic) Linking ISSN: 13889842 NLM ISO Abbreviation: Eur J Heart Fail Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1879-0844 |
|---|---|
| DOI: | 10.1002/ejhf.3614 |
